PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond

被引：261
|
作者：
Fattahi, Sadegh [1 ,2 ,3 ]
Amjadi-Moheb, Fatemeh [4 ]
Tabaripour, Reza [5 ]
Ashrafi, Gholam Hossein [6 ]
Akhavan-Niaki, Haleh [4 ]
机构：
[1] Babol Univ Med Sci, Student Res Comm, Babol, Iran
[2] Babol Univ Med Sci, Hlth Res Inst, Cellular & Mol Biol Res Ctr, Babol, Iran
[3] Pasteur Inst, North Res Ctr, Amol, Iran
[4] Babol Univ Med Sci, Dept Genet, Fac Med, Babol, Iran
[5] Islamic Azad Univ, Dept Cellular & Mol Biol, Babol Branch, Babol, Iran
[6] Kingston Univ London, Sch Life Sci Pharm & Chem, SEC Fac, Canc Theme, London KT12EE, England
来源：
LIFE SCIENCES | 2020年 / 262卷
关键词：
PI3K/AKT/mTOR pathway; Epigenetic modulation; Gastric cancer; Chemoresistance; Non-coding RNAs; Targeted therapy; PROMOTES CISPLATIN RESISTANCE; INHIBITS CELL-PROLIFERATION; ABERRANT DNA METHYLATION; HUMAN OVARIAN-CANCER; NF-KAPPA-B; AKT INHIBITOR; UP-REGULATION; PHOSPHOINOSITIDE; 3-KINASES; MESENCHYMAL TRANSITION; SCAFFOLDING FUNCTION;
D O I：
10.1016/j.lfs.2020.118513
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
PI3K/AKT/mTOR pathway is one of the most important signaling pathways involved in normal cellular processes. Its aberrant activation modulates autophagy, epithelial-mesenchymal transition, apoptosis, chemoresistance, and metastasis in many human cancers. Emerging evidence demonstrates that some infections as well as epigenetic regulatory mechanisms can control PI3K/AKT/mTOR signaling pathway. In this review, we focused on the role of this pathway in gastric cancer development, prognosis, and metastasis, with an emphasis on epigenetic alterations including DNA methylation, histone modifications, and post-transcriptional modulations through non-coding RNAs fluctuations as well as H. pylori and Epstein-Barr virus infections. Finally, we reviewed different molecular targets and therapeutic agents in clinical trials as a potential strategy for gastric cancer treatment through the PI3K/AKT/mTOR pathway.
引用
收藏
页数：16
相关论文
共 50 条
  • [31] PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
    Li, Xiaoman
    Wu, Changjing
    Chen, Nianci
    Gu, Huadi
    Yen, Allen
    Cao, Liu
    Wang, Enhua
    Wang, Liang
    ONCOTARGET, 2016, 7 (22) : 33440 - 33450
  • [32] EPS8L3 suppresses apoptosis and autophagy of gastric cancer through PI3K/AKT/mTOR signaling
    Licai You
    Lijing Xiao
    Shuxuan Jin
    Molecular & Cellular Toxicology, 2023, 19 : 373 - 381
  • [33] PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
    Wu, P.
    Hu, Y-Z
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (35) : 4326 - 4341
  • [34] PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy
    Gloria Irene Manfredi
    Alessandra Dicitore
    Germano Gaudenzi
    Michele Caraglia
    Luca Persani
    Giovanni Vitale
    Endocrine, 2015, 48 : 363 - 370
  • [35] Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance
    Ediriweera, Meran Keshawa
    Tennekoon, Kamani Hemamala
    Samarakoon, Sameera Ranganath
    SEMINARS IN CANCER BIOLOGY, 2019, 59 : 147 - 160
  • [36] Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
    Yu, Le
    Wei, Jessica
    Liu, Pengda
    SEMINARS IN CANCER BIOLOGY, 2022, 85 : 69 - 94
  • [37] Exploring the roles of ncRNAs in prostate cancer via the PI3K/AKT/mTOR signaling pathway
    Guo, Rongwang
    Shi, Liji
    Chen, Yonghui
    Lin, Canling
    Yin, Weihua
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [38] Berberine Improves Chemo-Sensitivity to Cisplatin by Enhancing Cell Apoptosis and Repressing PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer
    Kou, Yingying
    Tong, Bending
    Wu, Weiqing
    Liao, Xiangqing
    Zhao, Min
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [39] The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance
    Oscar Tapia
    Ismael Riquelme
    Pamela Leal
    Alejandra Sandoval
    Susana Aedo
    Helga Weber
    Pablo Letelier
    Enrique Bellolio
    Miguel Villaseca
    Patricia Garcia
    Juan Carlos Roa
    Virchows Archiv, 2014, 465 : 25 - 33
  • [40] Genetic variants in PI3K/Akt/mTOR pathway genes contribute to gastric cancer risk
    Ge, Yuqiu
    Liu, Hanting
    Qiu, Xiaonan
    Ma, Gaoxiang
    Wang, Haixiao
    Du, Mulong
    Wang, Meilin
    Zhao, Qinghong
    Tao, Guoquan
    Chu, Haiyan
    Zhang, Zhengdong
    GENE, 2018, 670 : 130 - 135
12345